These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6782927)

  • 21. Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
    Shen CY; Li KJ; Lai PH; Yu CL; Hsieh SC
    Clin Rheumatol; 2018 Mar; 37(3):749-756. PubMed ID: 28940121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine.
    Coleiro B; Marshall SE; Denton CP; Howell K; Blann A; Welsh KI; Black CM
    Rheumatology (Oxford); 2001 Sep; 40(9):1038-43. PubMed ID: 11561116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon.
    Marasini B; Cugno M; Agostoni A
    Arthritis Rheum; 1991 Feb; 34(2):255-6. PubMed ID: 1899793
    [No Abstract]   [Full Text] [Related]  

  • 24. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serpiginous choroidopathy associated with elevated factor VIII-von Willebrand factor antigen.
    King DG; Grizzard WS; Sever RJ; Espinoza L
    Retina; 1990; 10(2):97-101. PubMed ID: 2402559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular function parameters in idiopathic and quartz-induced progressive scleroderma].
    Haustein UF; Scheel H; Siegemund A; Krusche U
    Hautarzt; 1993 Nov; 44(11):717-22. PubMed ID: 8276590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
    Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
    J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
    Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
    Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction between VWF and FVIII in treating VWD.
    Miesbach W; Berntorp E
    Eur J Haematol; 2015 Nov; 95(5):449-54. PubMed ID: 25605439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity and sensitivity of immunohistochemical detection of factor VIII/von Willebrand factor antigen in formalin-fixed paraffin-embedded tissue.
    McComb RD; Jones TR; Pizzo SV; Bigner DD
    J Histochem Cytochem; 1982 Apr; 30(4):371-7. PubMed ID: 6801111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Availability of endothelial von Willebrand factor and platelet function in diabetic patients infused with a vasopressin analogue.
    Porta M
    Diabetologia; 1982 Nov; 23(5):452-5. PubMed ID: 6816652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ultrastructural localization of von Willebrand factor in endothelial cells.
    Warhol MJ; Sweet JM
    Am J Pathol; 1984 Nov; 117(2):310-5. PubMed ID: 6093546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
    Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
    Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
    Jones TR; Kao KJ; Pizzo SV; Bigner DD
    Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma levels of tumor necrosis factor and endothelial response in patients with chronic arterial obstructive disease or Raynaud's phenomenon.
    Cimminiello C; Arpaia G; Toschi V; Rossi F; Aloisio M; Motta A; Bonfardeci G
    Angiology; 1994 Dec; 45(12):1015-22. PubMed ID: 7985828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Factor VIII/von Willebrand factor complex (FVIII/vWF)].
    Yoshioka A
    Rinsho Byori; 1985 Feb; Spec No 61():73-85. PubMed ID: 3923232
    [No Abstract]   [Full Text] [Related]  

  • 39. Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis.
    Baele G; Matthijs E; Barbier F
    Acta Haematol; 1977; 57(5):290-7. PubMed ID: 403732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
    Gardinali M; Pozzi MR; Bernareggi M; Montani N; Allevi E; Catena L; Cugno M; Bottasso B; Stabilini R
    J Rheumatol; 2001 Apr; 28(4):786-94. PubMed ID: 11327251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.